CAC
Cowen and Company’s Tarsus Pharmaceuticals TARS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,197,385
| Closed | -$72.3M | – | 241 |
|
|
2024
Q3 | $72.3M | Hold |
2,197,385
| – | – | 2.43% | 10 |
|
|
2024
Q2 | $59.7M | Buy |
2,197,385
+74,855
| +4% | +$2.03M | 1.64% | 11 |
|
|
2024
Q1 | $77.2M | Buy |
2,122,530
+211,131
| +11% | +$7.67M | 2.99% | 6 |
|
|
2023
Q4 | $38.7M | Buy |
1,911,399
+114,626
| +6% | +$2.32M | 2.54% | 6 |
|
|
2023
Q3 | $31.9M | Sell |
1,796,773
-202,610
| -10% | -$3.6M | 2.23% | 7 |
|
|
2023
Q2 | $36.1M | Buy |
+1,999,383
| New | +$36.1M | 2.99% | 8 |
|
|
2022
Q4 | – | Sell |
-522,329
| Closed | -$8.94M | – | 657 |
|
|
2022
Q3 | $8.94M | Sell |
522,329
-12,195
| -2% | -$209K | 0.86% | 28 |
|
|
2022
Q2 | $7.8M | Hold |
534,524
| – | – | 0.75% | 32 |
|
|
2022
Q1 | $8.99M | Buy |
534,524
+20,235
| +4% | +$340K | 0.87% | 29 |
|
|
2021
Q4 | $11.6M | Hold |
514,289
| – | – | 1.05% | 19 |
|
|
2021
Q3 | $11.1M | Hold |
514,289
| – | – | 0.53% | 29 |
|
|
2021
Q2 | $14.9M | Buy |
+514,289
| New | +$14.9M | 0.78% | 21 |
|